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New Directions in Pain Research: Meeting Report
Molecules to Maladies
through tetrodotoxin-resistant sodium channels and
caused a hyperpolarizing shift in its activation curve and
in the steady-state inactivation curve. This observation
Jon D. Levine
National Institutes of Health Pain Center
University of California
San Francisco, California 94143 is important for understanding acute and chronic inflam-
matory pain states, since sensitization of primary affer-
ent nociceptors by prostaglandin E2 and also by other
hyperalgesic inflammatory mediators is believed to beAn overview of the rapidly changing field of pain re-
a major contributor to acute and chronic inflammatorysearch was presented at a recent meeting sponsored
pain states. The fact that this tetrodotoxin-resistant so-by the National Institutes of Health Pain Consortium.
dium current appears to be expressed almost exclu-This meeting brought together pain researchers from
sively in primary afferent nociceptors makes it a promis-the NIH, extramural pain researchers, and other basic
ing target for pain therapy that could have minimal sidescientists. This meeting review is organized along the
effects. In addition to such modulation, changes in thepath of the ªpainº signal, from the transduction pro-
number of sodium channels expressed may also con-cesses in the nociceptive terminal, through the relay of
tribute to changes in activity in primary afferent nocicep-information in the spinal cord, to the functional corre-
tors after traumatic nerve injury (i.e., in a neuroma) (De-lates of pain perception in the brain. Unfortunately, in
vor et al., 1993). Finally, data indicate that potassiumthis brief review it is possible to highlight only some of
channels are also involved in inflammatory mediatorthe fascinating research areas that were discussed.
sensitization (Nicol et al., 1997).
Ligand-gated ion channels play important roles in pe-ªIt Has to Start Somewhereº: the Primary
ripheral pain mechanisms as well. These include theAfferent Nociceptor Terminal
ATP-gated P2X3 channel, which is enriched in nocicep-Much of the recent excitement in the field of pain re-
tors (Chen et al., 1995). Since ATP is found in increasedsearch stems from discoveries of the molecular and
levels at sites of inflammation, and is known to activatecellular mechanisms that underlie transducer function in
nociceptors in vivo and in vitro, these channels probablyprimary afferent nociceptors. This work has significantly
contribute to inflammatory pain. In addition, a dorsalincreased our understanding of the first step in noci-
root ganglion neuron-specific proton-gated ion channelception.
has recently been cloned (dorsal root ganglion acidTransducers, Ion Channels, and Second Messengers
sensing ion channel [DRASIC; Waldmann et al., 1997]),Recent studies have identified key ion channels involved
which may mediate pain in acid environments such asin normal transduction processes as well as in modula-
in inflammatory lesions. Finally, a vanilloid (capsaicin)±tory processes, such as inflammatory mediator-induced
gated ion channel, activated by vanilloids and noxioussensitization of primary afferent nociceptors, which low-
heat, modulated by low pH, and specifically expresseders pain threshold. In particular, presenters highlighted
in primary afferent nociceptors, has also been clonedstudies of the transducers and receptors that mediate
(Caterina et al., 1997). This latter achievement has clini-chemical and thermal activation of primary afferent noci-
cal significance, since capsaicin, an excitotoxin, hasceptors. Other topics included recently cloned recep-
been shown to be effective in ameliorating certaintors for several chemical stimuli, including ATP, protons,
chronic pain states (Robbins et al., 1998). Because theyand capsaicin.
are only found in nociceptors, and play a role in nocicep-The most common class of primary afferent nocicep-
tion, the cloning of VR-1, DRASIC, and tetrodotoxin-tors (polymodal nociceptors) is activated by thermal and
resistant sodium channels provides unique molecularmechanical stimuli in the noxious range and by noxious
probes for studying these pain states in humans andchemicals. Thermal nociceptive transduction might in-
may help in developing experimental models to evaluatevolve both a nonselective cation channel that is acti-
new analgesic agents.vated by heat-induced elevation of intracellular calcium
Second messenger processes underlie the sensiti-level (Cesare and McNaughton, 1996; Reichling and Le-
zation of primary afferent nociceptors by inflammatoryvine, 1997) and a vanilloid (capsaicin) receptor (VR-1),
mediators after tissue injury. Many inflammatory media-which can be activated by heat in the noxious range
tors (e.g., prostaglandin E2, prostacyclin, serotonin, and(Caterina et al., 1997). Although the mechanisms under-
adenosine) are mediated through the cAMP secondlying mechanical transduction in nociceptors remain
messenger system (Hingtgen et al., 1995; England et al.,elusive, recent studies with C. elegans suggest that cy-
1996). Conversely, inhibition of inflammatory mediator-toskeletal deformation caused by mechanical stimula-
induced sensitization by m-opioid agonists, which maytion activates specific ion channels in mechanosensory
explain peripheral analgesic effects in animals and hu-receptor cells (Huang et al., 1995).
mans (Stein et al., 1991), is mediated through inhibitoryThe contribution of specific voltage-gated channels
G protein action.to inflammatory pain was also discussed. In particular,
Neurotrophic Factorsmodulation of tetrodotoxin-resistant sodium channels
Several participants discussed the contribution of neu-(SNS or PN3) plays a significant role in primary afferent
rotrophic factors in the processing of pain messages.nociceptor sensitization induced by inflammatory medi-
ators (Akopian et al., 1996; Gold et al., 1996). Prosta- Although multiple growth factors contribute to both sur-
vival and function of Ad (small-diameter myelinated) andglandin E2 was observed to increase the peak current
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C (unmyelinated) -fiber nociceptors, most studies have and intense in the presence of chronic inflammatory
pain than in acute pain (Abbadie et al., 1997; Allen etfocused on the role of nerve growth factor (NGF). NGF
al., 1997; Mantyh et al., 1997a). In rats, spinal intrathecallevels have been found to be upregulated in inflamma-
administration of substance P conjugated to the ribo-tion (Woolf et al., 1994; Ma and Woolf, 1997). Administra-
some inactivating protein saponin is internalized, selec-tion of NGF to rats produces hyperalgesia (tenderness)
tively destroys substance P receptor-containing neu-(Lewin et al., 1994), and in humans NGF produces a
rons, and selectively attenuates behavioral responsesprolonged muscular pain (Dyck et al., 1997). The low
to noxious stimuli (Mantyh et al., 1997b), suggesting aaffinity NGF (p75) receptor may contribute to the effects
potential target for novel therapy.of NGF on pain and hyperalgesia; this receptor is upreg-
A new era in the electrophysiology of dorsal hornulated in the presence of inflammation, and mice with
circuitry has been initiated with use of dissociated spinala deletion of p75 exhibit loss of heat injury±induced
cord cultures, coculture of spinal dorsal horn and dorsalhyperalgesia (Bergmann et al., 1997). Conversely, the
root ganglion neurons, and spinal cord slices with intacthigh affinity (TrkA) receptor has been reported to be
dorsal root. These methods are being used, for example,mutated in some patients with congenital insensitivity
to study the roles of NMDA receptors, calcium-perme-to pain.
able AMPA receptors, and presynaptic ATP receptorsWhat are potential mechanisms by which NGF con-
in dorsal horn nociceptive circuitry in fetal spinal cordtributes to inflammatory and neuropathic pain? NGF
(Gu and MacDermott, 1997).stimulates mast cells to release histamine and serotonin,
Pain Modulation in the Cord: Enhancementwhich can contribute to the development of pain (Lewin
Long term potentiation (LTP) was initially characterizedet al., 1994). In addition, animals that overexpress NGF
in the hippocampus and has been shown to have early,have increased cutaneous innervation by unmyelinated
intermediate, and late (protein synthesis) components;afferents, hyperresponsive nociceptors, and a distribu-
to be Ca21 and NMDA receptor dependent; and to betion of Ad fibers that is skewed such that many more
affected by growth factors (Kang and Schuman, 1995).have nociceptor properties (Stucky and Koltzenburg,
An LTP-like phenomenon has been shown to occur in1997). Enhanced pain response mediated by NGF may
nociceptive neurons at the level of the ªfirstº synapsealso be due to an increased level of neuropeptides in
and can enhance rostral transmission of the nociceptive
sensory neurons (Ji et al., 1996).
signal (Randic et al., 1993). This LTP-like phenomenon
NGF provides a potential target for the design of pain
is distinct from central sensitization, a heterosynaptic
therapies. For example, a TrkA±IgG fusion molecule and
facilitation of dorsal horn neurons that underlies tactile
anti-NGF antisera, which acts as an NGF antagonist,
allodynia (pain response to normally nonpainful stimuli)
decreases experimental inflammatory pain (Woolf et al.,
and sensory hyperalgesia (Ma and Woolf, 1996).
1994; McMahon et al., 1995; Ma and Woolf, 1997). This The second distinct phenomenon related to plasticity
treatment may also antagonze neuropathic pain, as evi- is a response to C-fiber injury in which sprouts of nonno-
denced in nerve injury pain models. It was suggested ciceptive myelinated afferent axons extend into regions
that tyrosine kinase inhibitors may therefore serve as of the dorsal horn that are normally the exclusive terri-
novel analgesic drugs for reducing effects produced by tory of nociceptive primary afferent terminals (Woolf et
NGF activation of TrkA. al., 1992). This sprouting may create a novel linkage of
nonnociceptive afferents to ªsecond orderº nociceptive
neurons in the dorsal horn and could explain why a
Telling It How It Is: Pain Processing nonnoxious stimulus ([Ab-fiber]±mediated) can evoke
in the Spinal Cord pain after nerve injury.
Recent advances have been made in understanding the Pain Modulation in the Cord: Inhibition
specific mechanisms involved in the transfer of nocicep- Transmission of nociceptive messages rostrally can be
tive information and additional processing at the spinal attenuated by circuits that inhibit transmitter release at
level (termed the ªfirstº synapse in the pain pathway). the level of the ªfirstº synapse in the dorsal horn. This
The ªFirstº Synapse: Transmitters and Receptors mechanism is exploited clinically by spinal infusion of
Complementing electrophysiological techniques, c-fos different agonists for neurotransmitter receptors (e.g.,
immunohistochemistry provides a straightforward ana- opioids).
tomical method for identifying populations of cells in
the spinal cord dorsal horn that respond to noxious No Brain, No Pain: Higher Level Processing
stimuli (Hunt et al., 1987). Further, recent studies that Of course, it is through induced activity in the cerebral
characterize internalization of specific receptors (namely cortex that pain is consciously appreciated (ªno brain,
the substance P receptor) after noxious stimulation pro- no painº). The study of pain consciousness or aware-
vide both anatomical and functional correlates of ªfirstº ness has greatly advanced with the development of new
synapse transmission. functional imaging technologies. The ability of the brain
Based upon the model of b-adrenergic receptor de- to modulate incoming pain information through descend-
sensitization (Yu et al., 1993), studies evaluating the role ing antinociceptive controls involving endogenous opi-
of substance P in transmission of nociceptive informa- oids, catecholamines, as well as other neurotransmitters,
tion at the level of the ªfirstº synapse confirm and extend has also been extensively studied by imaging.
work with antibody-labeled microprobes (Duggan and Imaging Pain
Hendry, 1986). The studies showed that substance P is Several research groups, using the techniques of func-
released after noxious stimulation and that the action tional magnetic resonance imaging (fMRI), positron emis-
sion tomography (PET) scanning (with radiolabeled waterof substance P in the spinal cord is more widespread
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Figure 1. Transmission along the Nociceptive Pathway (Courtesy of H. Fields) with Illustration of Mechanisms for Neuropathic Pain, Processing
Nociceptive Information at the ªFirstº Synapse, and Functional Mapping of Pain at the Level of the Cortex
The figure is compiled from published data and from reports presented at the meeting.
(A) PET images comparing cortical activation by different thermal stimuli applied to the hand.
(Top) The thermal ªgrillº is an illusion in which a painful heat sensation is evoked by nonpainful warm (408C) and cool (208C) stimuli applied
simultaneously. Whereas all thermal stimuli activate the insular cortex, the grill unmasks activation of the anterior cingulate cortex (arrow),
consistent with the selective activation of this region by noxious cold and heat (courtesy of A. [Bud] Craig).
(Bottom) Documentation of pathway for pain and temperature activity to the anterior cingulate cortex and insular cortex via lamina I spinotha-
lamic fibers. The left image shows lamina I terminations in the nucleus VMpo, which relays to the insula. The right image indicates lesions
identifying VMpo (arrows) as the site of nociceptive- and thermoreceptive-specific neuron recording (courtesy of A. [Bud] Craig).
(B) Fluorescent confocal microscope images of substance P receptor-like immunoreactivity in lamina I spinal neurons in the lumbar cord (L4).
The cell in the lower image is from a spinal cord from a rat that received an injection of capsaicin in the hindpaw and shows internalization
of the substance P receptor. The cell in the upper image is a control cell from the contralateral spinal cord (courtesy of P. Mantyh).
(C) Fluorescent image of an axon end microdissected from a chronic nerve end neuroma, immunolabeled with a polyclonal antibody raised
against purified sodium channel protein extracted from eel electroplax organ. Dense immunolabeling for sodium channel is present in the
neuroma (courtesy of M. Devor).
and receptor ligands), and neuroelectric source imaging implicated in attention tasks. Activity in this cortical site
may be produced by input from a pain-specific thalamichave begun to define the cortical and subcortical sites
involved in responses to acute noxious stimulation in nucleus (Craig et al., 1994). Interestingly, this area is
strongly activated by the thermal grill illusion, in whichchronic pain states and pain modulation.
One specific cortical area that has recently been impli- an array of alternating innocuous warm and cold bars
induces the sensation of burning pain (Craig et al., 1996).cated in pain perception is the anterior cingulate cortex.
This area ªlights upº with pain (experimental and clini- This demonstrates that a site activated during percep-
tion of pain can be induced in the absence of a peripheralcal); a separate area in the anterior cingulate has been
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noxious stimulus. This activity may be produced by in- contribute to observed variation between mouse strains
in tests of nociception and antinociception (Belknap etteractions of pain- and temperature-specific pathways
to the insular cortex. al., 1995).
GenderAnother finding emerging from these imaging studies
is that plastic changes occur on the ªbrainº level and are Despite a wealth of experimental literature on the effects
of gender on pain perception in animals and humans,reversible. Specifically, the altered cortical somatotopy
present in patients with phantom limb pain reverts to it is only recently that the importance of gender on anal-
gesic response has been evaluated clinically. In animalnormal when pain is alleviated (Birbaumer et al., 1997).
Future studies using newer imaging techniques with ex- studies, females exhibit increased sensitivity to noxious
stimuli, and pain responsiveness is influenced by sextremely high spatial and temporal resolution, like those
that have been applied to visual cortex, should improve steroid hormones. Furthermore, males display greater
morphine-induced antinociception than females andour understanding of the subjective perception of pain.
Figure 1 depicts recent mechanistic data on central these responses are also modulated by sex steroid hor-
mones (Cicero et al., 1996). Finally, in humans there isimaging as well as pain processing at the peripheral and
ªfirstº synapse levels. evidence that k-opioid analgesics are significantly more
effective in females (Gear et al., 1996). It should be notedNot Feeling So Good
Recent studies suggest that there is a third class of pain that although females report increased sensitivity and
decreased tolerance to electrical stimulation comparedsyndrome, distinct from neuropathic and inflammatory
pain syndromes, in which pain is related to the sickness with males, two additional factors may contribute to the
increased sensitivity topainful stimuli in females,namelyresponse that occurs with exposure to chemical com-
pounds and infectious agents. The state of illness (ªnot anxiety and hypervigilance (i.e., increased attention to
external stimulation and a preoccupation with pain sen-feeling wellº) has now been studied at the level of inter-
actions between the immune system (and cytokines) sations) (Lautenbacher and Rollman, 1993).
and circuits activated by a subset of subdiaphragmatic
vagal afferents (Watkins et al., 1994). Central changes Pain Syndromes: Mechanisms and Management
Although this meeting concentrated on pain mecha-occur to produce systemic heightened pain sensitivity
(i.e., hyperalgesia or ªhurting all overº). Other central nisms, a portion was devoted to clinical aspects of pain
research. Specific pain syndromes were discussed, in-components of the sickness response include fever,
activation of endocrine pathways, malaise, and an- cluding recent advances in understanding their mecha-
nisms and in themanagement of visceral, musculoskele-orexia.
tal, and neuropathic pain syndromes.
Clinical Pain Control: Placebo or ªthe Real Thingº
Genetic Background and Hormonal Milieu There is now an extensive and growing body of evidence
as Influences on Pain that a variety of empirical, traditional, and folk remedies
Classical and more modern techniques of genetic analy- can relieve pain. For some of these therapies, critics
sis arenow being applied to determine the geneticbases have suggested that there is no basis for their analgesic
for variation in nociceptive and antinociceptive respon- effect beyond placebo response. Placebo analgesia
sivity. These include (1) candidate gene analysis, in may operate through changing attentional focus, mood,
which a suspect gene is investigated by production of or expectation. These effects may be mediated through
knockout animals and comparison made of subsequent endogenous opioid peptides acting in circuits at both
nociceptive responsivity to that in normal animals; (2) brainstem and spinal levels. For example, placebo anal-
quantitative trait locus (QTL) analysis, in which many gesia in humans is significantly reduced by the opioid
strains are evaluated and a nociceptive response variant antagonist naloxone (Benedetti, 1996). In addition, a
is isolated and its genetic locus mapped; and (3) induced spinal cord to brainstem to spinal cord circuit, termed
mutagenesis followed by screening with nociceptive diffuse noxious inhibitory controls (Bing et al., 1991),
tests, further breeding, and genetic analysis. Candidate appears to contribute to effects of counterirritation meth-
gene analysis has revealed specific influences of the ods such as acupuncture.
PANK2 gene (encoding Met and Leu enkephalin), genes Neuropathic and Visceral/Musculoskeletal Pain
controlling tachykinins and their receptors, the three Neuropathic pain follows injury or disease of thenervous
opioid receptor genes (m, k, and d), the CB1 gene (which system, most commonly of peripheral nerves. It is often
encodes for a cannabinoid receptor), as well as others. severe and intractable and may not respond even to
Knockout experiments have demonstrated that the m-, powerful opiates. As such, it constitutes a major frontier
k-, and d-opioid receptors all influence the pain re- for pain research. Peripheral nerve injury leads to the
sponse but do so differentially depending on the experi- appearance of ectopic impulse discharge in large- and
mental pain paradigm used (Matthes et al., 1997). Since small-diameter primary afferent neurons (Amir and De-
pharmacological studies suggest that there are multiple vor, 1997). The resulting hyperexcitability yields not only
m-, k-, and d-opioid receptor subtypes, the knockout spontaneous ectopic discharge but also hypersensitiv-
technique will be particularly important for the study ity to a broad range of stimuli, including mechanical
of opioid receptors. However, at present there is no displacement and noradrenaline released by sympa-
molecular basis for identifying the individual receptor thetic efferent activity (sympathetically maintained pain)
subtypes for the three classes of opioid receptors. QTL (McLachlan et al., 1993). Musculoskeletal and visceral
analysis of pain traits has also provided evidence that pain states are characterized by hyperalgesia (tender-
ness). In contrast to nociceptors in the cutaneous andvariation in expression of m-opioid receptor gene may
Meeting Report
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Chen, C.C., Akopian, A.N., Sivilotti, L., Colquhoun, D., Burnstock,musculoskeletal systems, visceral nociceptors are qui-
G., and Wood, J.N. (1995). A P2X purinoceptor expressed by aescent and relatively insensitive to mechanical stimuli
subset of sensory neurons. Nature 377, 428±431.unless the tissue is inflamed (Cervero and Janig, 1992),
Cicero, T.J., Nock, B., and Meyer, E.R. (1996). Gender-related differ-whereupon they undergo phenotypic changes.
ences in the antinociceptive properties of morphine. J. Pharmacol.
In conclusion, the participants at the workshop pro- Exp. Ther. 279, 767±773.
vided an exciting view of a rapidly advancing field of Craig, A.D., Reiman, E.M., Evans, A., and Bushnell, M.C. (1996).
research. More than a half century after Sherrington Functional imaging of an illusion of pain. Nature 384, 258±260.
introduced the term ªnociceptorº into the scientific liter- Craig, A.D., Bushnell, M.C., Zhang, E.T., and Blomqvist, A. (1994).
ature and over a quarter century after Melzack and Wall A thalamic nucleus specific for pain and temperature sensation.
Nature 372, 770±773.gave us the Gate-Control Theory of pain, modern experi-
mental methods have transformed the field, carrying it Devor, M., Govrin-Lippmann, R., and Angelides, K. (1993). Na1 chan-
nel immunolocalization in peripheral mammalian axons andchangesbeyond the issues of neural specificity and patterning,
following nerve injury and neuroma formation. J. Neurosci. 13, 1976±allowing us to answer questions with greater precision
1992.and certainty. The major focus of this meeting was the
Duggan, A.W., and Hendry, I.A. (1986). Laminar localization of theprimary afferent nociceptor, which we have learned is
sites of release of immunoreactive substance P in the dorsal horn
remarkably plastic in its response to stimuli. How pri- with antibody-coated microelectrodes. Neurosci. Lett. 68, 134±140.
mary afferent activity actually produces pain, however,
Dyck, P.J., Peroutka, S., Rask, C., Burton, E., Baker, M.K., Lehman,
particularly in the setting of injury, involves complex K.A., Gillen, D.A., Hokanson, J.L., and O'Brien, P.C. (1997). Intrader-
interactions at the level of the spinal cord and brain. mal recombinant human nerve growth factor induces pressure allo-
Many of the models and techniques presented at this dynia and lowered heat-pain threshold in humans. Neurology 48,
501±505.conference have great potential to promote a cohesive
England, S., Bevan, S., and Docherty, R.J. (1996). PGE2 modulatesunderstanding of how the pain experience arises, how
the tetrodotoxin-resistant sodium current in neonatal rat dorsal rootit is modulated within thenervous system, and ultimately
ganglion neurones via the cyclic AMP-protein kinase A cascade. J.how it may be successfully treated.
Physiol. (Lond.) 495, 429±440.
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